Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
218 hedge funds and large institutions have $3.84B invested in Syneos Health, Inc. Class A Common Stock in 2018 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 81 increasing their positions, 62 reducing their positions, and 35 closing their positions.
74% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 35
31% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 62
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
12% more funds holding
Funds holding: 194 → 218 (+24)
0% less call options, than puts
Call options by funds: $2.31M | Put options by funds: $2.32M
17% less capital invested
Capital invested by funds: $4.62B → $3.84B (-$787M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$107M |
| 2 |
Millennium Management
New York
|
+$43.5M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$30.9M |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$29.5M |
| 5 |
Goldman Sachs
New York
|
+$27.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$60M |
| 2 |
JP
Jana Partners
New York
|
-$57.6M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$55.6M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
-$34.8M |
| 5 |
SC
Samlyn Capital
New York
|
-$30M |
SYNH Hedge Fund Activity: Q1 2018 in Review
218 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q1 2018, worth a combined $3.84B — down 17% from $4.62B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new SYNH positions and 35 closed out — a net gain of 26 holders — while 81 added to existing stakes and 62 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $107M. The largest seller was Balyasny Asset Management, cutting an estimated $60M.
- 218 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q1 2018, up from 194 in Q4 2017.
- Funds reported $3.84B of Syneos Health, Inc. Class A Common Stock stock for Q1 2018, down 17% quarter-over-quarter.
- 61 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q1 2018 and 35 closed out, a net change of +26 holders.
- The largest Syneos Health, Inc. Class A Common Stock buyer in Q1 2018 was Wellington Management Group, an estimated $107M added.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q1 2018 was Balyasny Asset Management, an estimated $60M sold.
Based on aggregated 13F filings for Q1 2018.